Thermo Fisher Scientific and Hamilton Partner to Offer Storage Solutions
|
By LabMedica International staff writers Posted on 09 Nov 2016 |

Image: The Decapper 500 and 550 systems are designed for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories (Photo courtesy of Business Wire).
Thermo Fisher Scientific Inc. (Waltham, MA, USA) and Hamilton Storage (Reno, NV, USA) have entered into a partnership to offer the fully automated Thermo Scientific Decapper 500 and 550 Series tube capping systems for researchers seeking to streamline their sample storage processes.
Biological samples are usually stored in multiple tube types, requiring users to buy multiple decappers. The new decapper system does the work of multiple systems and features Quick Switch technology that seamlessly transitions between different tube and rack types. Users can now cap and decap both Thermo Scientific Matrix and Nunc automation tubes without being required to own multiple pieces of equipment.
The Decapper 500 and 550 systems fill a gap between low-throughput, manual eight-channel handheld decappers and high throughput, entire-rack decappers for automated workstations. They are both suitable for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories doing compound storage, high-throughput screening, biobanking and genomic storage.
“To address customer demand for more flexible and functional decapping equipment, Thermo Fisher partnered with Hamilton Storage, an industry leader in cryogenic sample storage systems,” said Chris Tsourides, senior business director, Thermo Fisher Scientific. “These two new decappers show what’s possible when two industry innovators join forces. Together, we’re delivering significant time and cost savings to scientists all over the world.”
“We constantly seek new ways to streamline customer efficiencies, and with Thermo Fisher as a partner, our commitment is further strengthened,” adds Matt Hamilton, president of Hamilton Storage. “This means that our mutual customers will benefit from a robust, time-saving and integrated-friendly workflow solution.”
Related Links:
Thermo Fisher Scientific
Hamilton Storage
Biological samples are usually stored in multiple tube types, requiring users to buy multiple decappers. The new decapper system does the work of multiple systems and features Quick Switch technology that seamlessly transitions between different tube and rack types. Users can now cap and decap both Thermo Scientific Matrix and Nunc automation tubes without being required to own multiple pieces of equipment.
The Decapper 500 and 550 systems fill a gap between low-throughput, manual eight-channel handheld decappers and high throughput, entire-rack decappers for automated workstations. They are both suitable for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories doing compound storage, high-throughput screening, biobanking and genomic storage.
“To address customer demand for more flexible and functional decapping equipment, Thermo Fisher partnered with Hamilton Storage, an industry leader in cryogenic sample storage systems,” said Chris Tsourides, senior business director, Thermo Fisher Scientific. “These two new decappers show what’s possible when two industry innovators join forces. Together, we’re delivering significant time and cost savings to scientists all over the world.”
“We constantly seek new ways to streamline customer efficiencies, and with Thermo Fisher as a partner, our commitment is further strengthened,” adds Matt Hamilton, president of Hamilton Storage. “This means that our mutual customers will benefit from a robust, time-saving and integrated-friendly workflow solution.”
Related Links:
Thermo Fisher Scientific
Hamilton Storage
Latest Industry News
- WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
- BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
- Abbott Acquires Cancer-Screening Company Exact Sciences
- Roche and Freenome Collaborate to Develop Cancer Screening Tests
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
- Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
- Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
- GSI Group Acquires Blood Processing Equipment Manufacturer GenesisBPS
- ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases
- Lumiquick Acquires Aoxre to Expand Global IVD and Research Capabilities
Channels
Clinical Chemistry
view channel
Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
Multiple myeloma is an incurable cancer of the bone marrow, and while many patients now live for more than a decade after diagnosis, a significant proportion relapse much earlier with poor outcomes.... Read more
Compact Raman Imaging System Detects Subtle Tumor Signals
Accurate cancer diagnosis often depends on labor-intensive tissue staining and expert pathological review, which can delay results and limit access to rapid screening. These conventional methods also make... Read moreMolecular Diagnostics
view channel
Blood Test Predicts Crohn’s Disease Years Before Symptoms Appear
Crohn’s disease is a chronic inflammatory disorder of the gastrointestinal tract that causes persistent digestive symptoms, pain, and fatigue, often leading to lifelong treatment. Incidence rates are rising... Read more
DNA Testing of Colorectal Polyps Improves Insight into Hereditary Risks
Colorectal cancer is among the most common cancers in Western countries, and hereditary factors are involved in about 5–10% of cases, particularly in younger patients. Individuals with large numbers of... Read moreHematology
view channel
AI Algorithm Effectively Distinguishes Alpha Thalassemia Subtypes
Alpha thalassemia affects millions of people worldwide and is especially common in regions such as Southeast Asia, where carrier rates can reach extremely high levels. While the condition can have significant... Read more
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read moreImmunology
view channel
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
New Test Measures How Effectively Antibiotics Kill Bacteria
Antibiotics are typically evaluated by how well they inhibit bacterial growth in laboratory tests, but growth inhibition does not always mean the bacteria are actually killed. Some pathogens can survive... Read more
New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics
Antibiotic resistance is rising worldwide, threatening the effectiveness of treatments for major infectious diseases, including tuberculosis (TB). Resistance to key TB drugs, such as bedaquiline, is of... Read morePathology
view channel
AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery
Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Deep Learning–Based Method Improves Cancer Diagnosis
Identifying vascular invasion is critical for determining how aggressive a cancer is, yet doing so reliably can be difficult using standard pathology workflows. Conventional methods require multiple chemical... Read more
ADLM Updates Expert Guidance on Urine Drug Testing for Patients in Emergency Departments
Urine drug testing plays a critical role in the emergency department, particularly for patients presenting with suspected overdose or altered mental status. Accurate and timely results can directly influence... Read moreTechnology
view channel
AI-Generated Sensors Open New Paths for Early Cancer Detection
Cancers are far easier to treat when detected early, yet many tumors remain invisible until they are advanced or have recurred after surgery. Early-stage disease often produces signals that are too weak... Read more







